CVEvulnerability

CVE-2007-6763

8.8 HIGH Published 2019-07-31 Modified 2026-06-16 Official page ↗
Status
Modified
Published
2019-07-31
Last modified
2026-06-16
Assigner
[email protected]
CVSS 3.0 ([email protected])
8.8 HIGH — CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS 2.0 ([email protected])
6.5 MEDIUM — AV:N/AC:L/Au:S/C:P/I:P/A:P
Weaknesses
CWE-20

Description

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Affected configurations

• sas sas drug development (< 32drg02)

Related

Weakness · CWE (1)

  • CWE-20 Improper Input Validation weakness

References